Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GADOPENTETATE DIMEGLUMINE Cause Hypoaesthesia? 193 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 193 reports of Hypoaesthesia have been filed in association with GADOPENTETATE DIMEGLUMINE. This represents 25.7% of all adverse event reports for GADOPENTETATE DIMEGLUMINE.

193
Reports of Hypoaesthesia with GADOPENTETATE DIMEGLUMINE
25.7%
of all GADOPENTETATE DIMEGLUMINE reports
0
Deaths
17
Hospitalizations

How Dangerous Is Hypoaesthesia From GADOPENTETATE DIMEGLUMINE?

Of the 193 reports, 17 (8.8%) required hospitalization, and 7 (3.6%) were considered life-threatening.

Is Hypoaesthesia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GADOPENTETATE DIMEGLUMINE. However, 193 reports have been filed with the FAERS database.

What Other Side Effects Does GADOPENTETATE DIMEGLUMINE Cause?

Pain (231) Gadolinium deposition disease (209) Paraesthesia (206) Arthralgia (204) Burning sensation (190) Fatigue (188) Injury (187) Rash (186) Asthenia (177) Confusional state (175)

What Other Drugs Cause Hypoaesthesia?

ADALIMUMAB (7,423) ETANERCEPT (4,497) METHOTREXATE (4,175) RITUXIMAB (3,605) TOFACITINIB (3,324) PREDNISONE (3,239) TOCILIZUMAB (3,238) FINGOLIMOD (3,180) LENALIDOMIDE (3,127) SECUKINUMAB (3,079)

Which GADOPENTETATE DIMEGLUMINE Alternatives Have Lower Hypoaesthesia Risk?

GADOPENTETATE DIMEGLUMINE vs GADOPICLENOL GADOPENTETATE DIMEGLUMINE vs GADOTERATE MEGLUMINE GADOPENTETATE DIMEGLUMINE vs GADOTERIDOL GADOPENTETATE DIMEGLUMINE vs GADOVERSETAMIDE GADOPENTETATE DIMEGLUMINE vs GADOXETATE

Related Pages

GADOPENTETATE DIMEGLUMINE Full Profile All Hypoaesthesia Reports All Drugs Causing Hypoaesthesia GADOPENTETATE DIMEGLUMINE Demographics